DSDO Lenses Show Superior Axial Length Control in Pediatric Myopia Management: A Real-World Multicenter Study
Background
Myopia has reached epidemic proportions globally, with particularly rapid progression in pediatric populations. Axial elongation remains the primary biomarker for myopia progression, correlating strongly with future vision-threatening complications. While Defocus Incorporated Multiple Segments (DIMS) lenses have demonstrated efficacy in clinical trials, this real-world study provides the first multicenter comparison of next-generation Diversified Segmental Defocus Optimization (DSDO) lenses against both DIMS technology and natural history controls.
Study Design
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.